Novel treatment of gefitinib-resistant non-small-cell lung cancer
OwnerLai Han LEUNG, Xing Xing FAN +1inventors
InventorsLai Han LEUNG, Xing Xing FAN, Liang LIU
Life of this patent
Estimating the term…
Abstract
The present invention discloses a method of preventing and treating Gefitinib-resistant non-small-cell lung cancer, comprising administering an effective amount of an alkaloid. A pharmaceutical composition comprising an alkaloid admixed with a pharmaceutical carrier for treating Gefitinib-resistant non-small-cell lung cancer is also disclosed therein.
Claims8
A method of preventing and treating Gefitinib-resistant non-small-cell lung cancer, comprising administering an effective amount of an isoquinoline alkaloid.
A pharmaceutical composition comprising an isoquinoline alkaloid admixed with a pharmaceutical carrier for treating Gefitinib-resistant non-small-cell lung cancer.
A dietary supplement comprising an isoquinoline alkaloid admixed with a pharmaceutical carrier for treating Gefitinib-resistant non-small-cell lung cancer.
Dependencies are inferred from the claim text.